Peripheral neuropathy response to erythropoietin in type 2 diabetic patients with mild to moderate renal failure
Clinical Neurology and Neurosurgery, 06/20/2012
Hosseini–Zare MS et al. – It can be concluded that 6–month administration of erythropoietin (EPO)+gabapentin, or gabapentin alone in mild to moderate chronic kidney disease (CKD) patients with diabetic neuropathy could not improve nerve performance.



